LEXX today
$4.04-$0.60 (-12.93%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minBearish
5 minDescending Triangle
Daily trend turns up above $3.90
Key levels
Resistance$6.09
Resistance$5.23
Support$3.90
Support$2.43
Latest news & SEC filings
DealLexaria Bioscience signs new pharmaceutical agreement for DehydraTECH
DealLexaria Bioscience signs deal with undisclosed pharma firm to study DehydraTECH technology
NewsLexaria Bioscience grows patent portfolio to 70 patents
ProductLexaria Bioscience fills all slots in its GLP-1 trial with people
ProductLexaria Bioscience finishes enrollment in two oral semaglutide pilot studies
All LEXX news →About Lexaria Bioscience
Lexaria Bioscience develops DehydraTECH, a patented drug delivery platform that improves how the body absorbs medicines taken by mouth. The method pairs drug compounds with specific triglyceride-rich oils and carrier materials to boost uptake and allow lower doses. Its research covers incretin-based therapies, cannabinoids, nicotine, antivirals, and other molecules, targeting conditions such as diabetes, obesity, high blood pressure, and epilepsy. The firm licenses the technology to partners and runs its own studies.
Based on the company's 10-K filed Nov 28, 2025.
Nasdaq · Healthcare
Lexaria Bioscience Corp. (LEXX)
What Is the Price Target for LEXX?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is LEXX a Buy or Sell Right Now?
Thesis
- •Revenue growing 52.0% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LEXX.
Start Free Trial →Is LEXX Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B
Fair Value
$0.92
38
Moat Score
NONE
3/9
Piotroski Score
-10.2
Altman Z-Score
What Is Smart Money Doing with LEXX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →LEXX Growth Story
Revenue YoY
52.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-40.43%
FCF Growth YoY
-109.4%
Revenue Trend
STRONG
Dark Pool Trades for LEXX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for LEXX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:44:37 | $4.02 | 2,000 | $$8K | SELL |
| 22:22:43 | $4.73 | 1,000 | $$5K | BUY |
| 20:17:34 | $4.77 | 1,000 | $$5K | SELL |
| 16:29:45 | $4.51 | 1,000 | $$5K | SELL |
| 15:55:50 | $4.67 | 1,000 | $$5K | BUY |
5 dark pool trades shown · $$27K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Lexaria Bioscience Corp. (LEXX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LEXX — frequently asked questions
What is LEXX stock price today?
Lexaria Bioscience Corp. (LEXX) is at $4.04, down 12.93% (-$0.60) at the Nov 12, 2026 close.
Why is LEXX stock moving today?
Latest LEXX news — Nov 5, 2026: Lexaria Bioscience signs new pharmaceutical agreement for DehydraTECH · Nov 4, 2026: Lexaria Bioscience signs deal with undisclosed pharma firm to study DehydraTECH technology
Did LEXX beat earnings?
LEXX last reported on Jul 13, 2026: EPS -$0.08 vs -$0.09 expected — a beat of 11.1%.
Does LEXX pay a dividend?
LEXX does not currently pay a dividend.
What are LEXX support and resistance levels?
Support: $3.90, $2.43. Resistance: $5.23, $6.09, $10.30.
What are insiders doing with LEXX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on LEXX?
Nov 5, 2026: Lexaria Bioscience signs new pharmaceutical agreement for DehydraTECH · Nov 4, 2026: Lexaria Bioscience signs deal with undisclosed pharma firm to study DehydraTECH technology · Oct 30, 2026: Lexaria Bioscience grows patent portfolio to 70 patents